Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert group
Andrej Janež, Emir Muzurović, Anca Pantea Stoian, Martin Haluzı́k, Cristian Guja, Leszek Czupryniak, Lea Duvnjak, Nebojša Lalić, Tsvetalina Tankova, Paweł Bogdański, Νικόλαος Παπάνας, Josè Silva Nunes, Péter Kempler, Zlatko Fras, Manfredi Rizzo
Topics & Concepts
MedicineLiraglutideDulaglutideSemaglutideGlucagon-like peptide 1 receptorIncretinGlucagon-like peptide-1Type 2 Diabetes MellitusInternal medicineClinical trialType 2 diabetesDiabetes mellitusExenatideEndocrinologyReceptorAgonistDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerDiabetes Management and Research